Clinical and laboratory predictive markers for acute dengue infection

BackgroundEarly diagnosis of dengue virus infection during the febrile stage is essential for adjusting appropriate management. This study is to identify the predictive markers of clinical and laboratory findings in the acute stage of dengue infection during a major outbreak of dengue virus type 1 that occurred in southern Taiwan during 2007. A retrospective, hospital-based study was conducted at a university hospital in southern Taiwan from January to December, 2007. Patient who was reported for clinically suspected dengue infection was enrolled. Laboratory-positive dengue cases are confirmed by enzyme-linked immunosorbent assay of specific dengue IgM, fourfold increase of dengue-specific IgG titers in convalescent serum, or by reverse transcription-polymerase chain reaction (RT-PCR) of dengue virus.ResultsThe suspected dengue cases consist of 100 children (≤ 18 years) and 481 adults. Among the 581 patients, 67 (67%) children and 309 (64.2%) adults were laboratory-confirmed. Patients who had laboratory indeterminate were excluded. Most cases were uncomplicated and 3.8% of children and 2.9% of adults developed dengue hemorrhagic fever or dengue shock syndrome (DHF/DSS). The overall mortality rate in those with DHF/DSS was 7.1%, and the average duration of hospitalization was 20 days. The most common symptoms/signs at admission were myalgia (46.8%), petechiae (36.9%) and nausea/vomiting (33.5%). The most notable laboratory findings included leukopenia (2966 ± 1896/cmm), thrombocytopenia (102 ± 45 × 103/cmm), prolonged activated partial thromboplastin time (aPTT) (45 ± 10 s), and elevated serum levels of aminotransferase (AST, 166 ± 208 U/L; ALT, 82 ± 103 U/L) and low C - reactive protein (CRP) (6 ± 11 mg/L). Based on the clinical features for predicting laboratory-confirmed dengue infection, the sensitivities of typical rash, myalgia, and positive tourniquet test are 59.2%, 46.8%, and 34.2%, while the specificities for above features are 75.4%, 53.5% and 100%, respectively. The positive predictive value (PPV) for combination of leukopenia, thrombocytopenia (< 150 × 103/cmm), elevated aminotransferase (AST/ALT > 1.5) and low CRP (< 20 mg/L) is 89.5%, while the negative predictive value is 37.4%. Furthermore, the PPV of the combination was increased to 93.1% by adding prolonged aPTT (>38 secs).ConclusionsLeukopenia, thrombocytopenia, elevated aminotransferases, low CRP and prolonged aPTT, were useful predictive markers for early diagnosis of dengue infection during a large outbreak in southern Taiwan.

[1]  C. Romero-Vivas,et al.  Altered Enzyme-Linked Immunosorbent Assay Immunoglobulin M (IgM)/IgG Optical Density Ratios Can Correctly Classify All Primary or Secondary Dengue Virus Infections 1 Day after the Onset of Symptoms, when All of the Viruses Can Be Isolated , 2006, Clinical and Vaccine Immunology.

[2]  S. Yoksan,et al.  Evaluation of dengue nonstructural protein 1 antigen strip for the rapid diagnosis of patients with dengue infection. , 2009, Diagnostic microbiology and infectious disease.

[3]  Mei-Chih Huang,et al.  Knowledge, attitude, and practice of dengue disease among healthcare professionals in southern Taiwan. , 2013, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  S. Hadinegoro,et al.  The revised WHO dengue case classification: does the system need to be modified? , 2012, Paediatrics and international child health.

[5]  M. Su,et al.  Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  V. Lee,et al.  Predictive value of simple clinical and laboratory variables for dengue hemorrhagic fever in adults. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  Rosanna W. Peeling,et al.  Evaluation of diagnostic tests: dengue , 2010, Nature Reviews Microbiology.

[8]  Debarati Guha-Sapir,et al.  Dengue fever: new paradigms for a changing epidemiology , 2005, Emerging themes in epidemiology.

[9]  E. Undurraga,et al.  Economic and Disease Burden of Dengue in Southeast Asia , 2013, PLoS neglected tropical diseases.

[10]  Y. Leo,et al.  Utilities and Limitations of the World Health Organization 2009 Warning Signs for Adult Dengue Severity , 2013, PLoS neglected tropical diseases.

[11]  P. Shu,et al.  Laboratory-based dengue surveillance in Taiwan, 2005: a molecular epidemiologic study. , 2007, The American journal of tropical medicine and hygiene.

[12]  S. Halstead,et al.  Dengue , 1872, The Lancet.

[13]  Yu-Chung Kuo,et al.  Development of Group- and Serotype-Specific One-Step SYBR Green I-Based Real-Time Reverse Transcription-PCR Assay for Dengue Virus , 2003, Journal of Clinical Microbiology.

[14]  D. Gubler,et al.  Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses , 2004, Nature Medicine.

[15]  A. Wilder-Smith,et al.  Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  E. Harris,et al.  Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity , 2011, PLoS neglected tropical diseases.

[17]  Y. S. Lin,et al.  Immunopathogenesis of dengue virus infection. , 2001, Journal of biomedical science.

[18]  Eli Schwartz,et al.  Dengue in travelers. , 2005, The New England journal of medicine.

[19]  M. Ferreira,et al.  Dengue fever in Brazilian adults and children: assessment of clinical findings and their validity for diagnosis , 2003, Annals of tropical medicine and parasitology.

[20]  D. Gubler,et al.  Epidemic dengue 1 in Brazil, 1986: evaluation of a clinically based dengue surveillance system. , 1990, American journal of epidemiology.

[21]  Tyen‐Po Chen,et al.  Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[22]  R. Edelman Dengue vaccines approach the finish line. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  S. Halstead,et al.  Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. , 2009, The American journal of tropical medicine and hygiene.

[24]  J. Lang,et al.  Early clinical features of dengue infection in Puerto Rico. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  S. Halstead More Dengue, More Questions , 2005, Emerging infectious diseases.

[26]  A. Nisalak,et al.  Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.

[27]  K. N. B. Nunes,et al.  Evaluation of an immunoglobulin M-specific capture enzyme-linked immunosorbent assay for rapid diagnosis of dengue infection. , 2011, Journal of virological methods.

[28]  B. Ligon,et al.  Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention. , 2005, Seminars in pediatric infectious diseases.

[29]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[30]  J. Steiner,et al.  Chart reviews in emergency medicine research: Where are the methods? , 1996, Annals of emergency medicine.

[31]  P. Shu,et al.  Current Advances in Dengue Diagnosis , 2004, Clinical Diagnostic Laboratory Immunology.

[32]  M. Aye,et al.  Risk factors in dengue shock syndrome. , 1997, The American journal of tropical medicine and hygiene.